Literature DB >> 22033892

Small bowel perforation secondary to metastatic non-small cell lung cancer. A rare entity with a dismal prognosis.

Nikolaos S Salemis1, Efstathios Nikou, Christos Liatsos, Christos Gakis, Grigorios Karagkiouzis, Stavros Gourgiotis.   

Abstract

PURPOSE: The incidence of gastrointestinal metastases from lung cancer is higher than previously thought as they have been reported in 2-14% of the cases in autopsy studies. However, clinically significant metastases are rare. Small bowel perforation secondary to metastatic non-small cell lung cancer is a very rare clinical entity. The aim of this study is to describe a case of ileal perforation in a patient with intestinal metastases of a non-small cell lung cancer, along with a review of the literature.
METHODS: A 57-year-old male with a history of non-small cell lung cancer was referred to our emergency department with signs and symptoms of acute surgical abdomen. A computed tomography scan demonstrated dilated small bowel loops, liver deposits, and signs of perforation of an intra-abdominal hollow viscus.
RESULTS: Emergency exploratory laparotomy revealed diffuse purulent peritonitis and a perforated ileal tumor. A segmental small bowel resection and primary anastomosis were performed. Histological and immunohistochemical findings were consistent with a metastatic non-small cell lung carcinoma. Additional evaluation revealed widespread metastatic disease. Unfortunately, despite adjuvant treatment, the patient died of progressive disease 2 months after surgery.
CONCLUSIONS: Small bowel perforation due to metastatic non-small cell lung cancer is a very rare clinical entity. The possibility of small bowel metastases should be kept in mind in patients with lung cancer presenting with an acute abdomen. Intestinal perforation occurs in advanced stages and is usually a sign of widespread disease. Aggressive surgery can provide effective palliation and may improve short-term survival. The prognosis is however dismal.

Entities:  

Mesh:

Year:  2012        PMID: 22033892     DOI: 10.1007/s12029-011-9329-2

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  26 in total

1.  Small intestinal metastasis from small cell lung cancer.

Authors:  Kouji Kanemoto; Kouichi Kurishima; Hiroichi Ishikawa; Seiji Shiotani; Hiroaki Satoh; Morio Ohtsuka
Journal:  Intern Med       Date:  2006-09-15       Impact factor: 1.271

2.  Abdominal metastases from lung cancer resulting in small bowel perforation: report of three cases.

Authors:  George Savanis; George Simatos; Ioanna Lekka; Shawki Ammari; Christophoros Tsikkinis; Anastasios Mylonas; Eythymios Kafasis; Athanasios Nissiotis
Journal:  Tumori       Date:  2006 Mar-Apr       Impact factor: 2.098

3.  [Primary lung carcinoma with intestinal metastases: 3 cases in a series of 420 patients].

Authors:  Juan Antonio Gómez-Patiño; Carlos Sánchez Almaraz; María Isabel Torres Sánchez
Journal:  Arch Bronconeumol       Date:  2007-08       Impact factor: 4.872

4.  Gastro-intestinal metastasis of primary lung carcinoma: clinical presentations and outcome.

Authors:  Chih-Jen Yang; Jhi-Jhu Hwang; Wang-Yi Kang; Inn-Wen Chong; Tung-Heng Wang; Chau-Chyun Sheu; Jong-Rung Tsai; Ming-Shyan Huang
Journal:  Lung Cancer       Date:  2006-09-27       Impact factor: 5.705

5.  Emergency abdominal surgery for small bowel perforation secondary to metastatic lung cancer.

Authors:  T Yokota; Y Yamada; N Sakata; S Kikuchi; Y Kunii; F Tezuka; H Suzuki; H Yamauchi
Journal:  Tohoku J Exp Med       Date:  1999-07       Impact factor: 1.848

6.  Successful treatment of a bowel perforation after chemotherapy for Burkitt lymphoma.

Authors:  Stephanie R Goldberg; Kamar Godder; David A Lanning
Journal:  J Pediatr Surg       Date:  2007-03       Impact factor: 2.545

Review 7.  A case and review of bowel perforation secondary to metastatic lung cancer.

Authors:  Robert A Garwood; Mark D Sawyer; E J Ledesma; Eugene Foley; Jeffrey A Claridge
Journal:  Am Surg       Date:  2005-02       Impact factor: 0.688

8.  Gastrointestinal metastases from primary lung cancer.

Authors:  Akihiro Yoshimoto; Kazuo Kasahara; Atsuhiro Kawashima
Journal:  Eur J Cancer       Date:  2006-10-31       Impact factor: 9.162

Review 9.  Small bowel metastases from primary lung carcinoma: a rarity waiting to be found?

Authors:  D M Mosier; R S Bloch; P L Cunningham; S A Dorman
Journal:  Am Surg       Date:  1992-11       Impact factor: 0.688

10.  Primary lung cancer presenting with gastrointestinal tract involvement: clinicopathologic and immunohistochemical features in a series of 18 consecutive cases.

Authors:  Giulio Rossi; Alessandro Marchioni; Elena Romagnani; Federica Bertolini; Lucia Longo; Alberto Cavazza; Fausto Barbieri
Journal:  J Thorac Oncol       Date:  2007-02       Impact factor: 15.609

View more
  5 in total

Review 1.  The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer.

Authors:  Elizabeth A David; James M Clark; David T Cooke; Joy Melnikow; Karen Kelly; Robert J Canter
Journal:  J Thorac Oncol       Date:  2017-08-24       Impact factor: 15.609

Review 2.  Gastrointestinal hemorrhage due to ileal metastasis from primary lung cancer.

Authors:  Wei Liu; Wei Zhou; Wei-Lin Qi; Ya-Dan Ma; Yun-Yun Xu
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

3.  Gastrointestinal metastasis of primary lung cancer: An analysis of 366 cases.

Authors:  Yue Hu; Noah Feit; Yanqin Huang; Wenhong Xu; Shu Zheng; Xiuzhen Li
Journal:  Oncol Lett       Date:  2018-04-25       Impact factor: 2.967

4.  Small bowel perforation and death caused by anaplastic thyroid carcinoma metastasis in a patient with concomitant colonic and bilateral breast carcinoma.

Authors:  Jan Hrudka; Ivana Švadlenková
Journal:  Autops Case Rep       Date:  2021-03-26

5.  Bowel perforation secondary to metastatic lung cancer: Report of two cases with literature review.

Authors:  Alberto Garavello; Pietro Fransvea; Stefano Rossi; Francesco Giacovazzo; Vincenza Marino
Journal:  Int J Surg Case Rep       Date:  2018-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.